Alexandra Balcom
Chief Financial Officer; Director · 7 filings · Latest: Jul 15, 2026
CRESCENT BIOPHARMA, INC.
Nuvalent, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NUVL | Alexandra Balcom | — | Sep 30, 2024 | Proposed Sale | $102.12 | 30,000 | $3.1M | — |
← Previous
Page 2 of 2